Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

JotPsych Launches Integrated E-Prescribing for Behavioral Health


News provided by

JotPsych

Feb 23, 2026, 10:00 ET

Share this article

Share toX

Share this article

Share toX

WASHINGTON, Feb. 23, 2026 /PRNewswire/ -- JotPsych today announced JotRx, an integrated e-prescribing system that lets clinicians move from session recording to note completion to prescription, all without leaving the patient record.

With JotRx, JotPsych now operates as a full clinical and revenue-cycle platform for behavioral-health prescribers. What began as a documentation engine built specifically for behavioral health now includes scheduling and calendar management, patient communications, structured forms and testing instruments, lab order generation, payer-aware documentation and audit intelligence (JotAudit), integrated billing and claims management, and certified e-prescribing. Clinicians can manage the entire lifecycle of care, from intake to prescription to compliant claim submission, within a single, connected patient record.

One Unified System

Many behavioral-health prescribers still juggle multiple systems: one for documentation, another for e-prescribing, and sometimes a third for billing. Each handoff adds time, friction, and risk of stale information. JotRx eliminates that fragmentation by tying prescribing directly to the patient record.

"Prescribers were already spending their entire session inside JotPsych," said Nathan Peereboom, CEO and co-founder of JotPsych. "Recording, documenting, reviewing history, checking compliance. That's most of their clinical day. They kept telling us: just let us prescribe here too. So we built it."

Prescribing From the Patient Record

JotRx is built into JotPsych at the patient level so clinicians can launch prescribing in the flow of care without changing how they run sessions.

Specifically:

  • Launch from where you work. Clinicians access the patient's prescribing record directly from the patient page, opening a secure DoseSpot prescribing window without leaving JotPsych.
  • No separate login. Once a prescriber completes setup, DoseSpot is connected to their JotPsych account. No re-authentication required.
  • Medication stays in sync. Prescriptions written in DoseSpot flow back into JotPsych so the patient's medication list stays current alongside the chart. Medication decisions are immediately reflected in the clinical note and available for coding, medical-necessity validation, and audit logic inside JotAudit.
  • Full e-prescribing capabilities. Access DoseSpot's complete Surescripts-certified network, including EPCS for Schedule II–V controlled substances, pharmacy search, drug-drug interaction alerts, and formulary checks.

"Clinicians want one system they can work out of," said Jackson Bierfeldt, CTO and co-founder of JotPsych. "When prescribing lives next to the note and the patient history, the whole workflow gets simpler. That's what we're building."

Certified, Secure E-Prescribing Through DoseSpot

JotRx is delivered through a partnership with DoseSpot (PRN Software), integrating the certified DoseSpot 8.0 EPCS module into JotPsych's native platform. DoseSpot provides access to the Surescripts-certified network supporting NewRx, RxRenewal, CancelRx, RxChange, RxFill, formulary checks, eligibility, medication history, and EPCS for Schedule II–V medications. The integration maintains certified transaction structures, provider directory compliance, and secure message transmission standards.

In connection with this launch, JotPsych underwent an independent 21 CFR 1311 integration review conducted by Drummond Group. The review evaluated user provisioning, logical access controls, prescription creation and signing workflows, two-factor authentication, audit logging, and reporting. Drummond Group assessed that JotPsych's integration meets the intent of the requirements of 21 CFR 1311 for the creation and electronic transmission of controlled substance prescriptions.

"DoseSpot brings a mature, Surescripts-certified prescribing infrastructure," said Jackson Bierfeldt, CTO and co-founder of JotPsych. "By integrating it directly into the JotPsych patient record and RCM engine, we've created a prescribing workflow that is both compliant and financially aligned."

Cleaner Claims, Less Audit Exposure

For clinics using JotPsych's RCM services, JotRx creates a closed loop between prescribing, documentation, and reimbursement. Because prescriptions sync back into the patient record, medication management services, complexity indicators, and controlled-substance documentation are captured in a way that supports accurate CPT coding and claim defensibility. This reduces discrepancies between what was prescribed, what was documented, and what was billed.

JotPsych estimates that eliminating duplicate patient lookup and system-switching can save prescribers approximately 2–4 minutes per prescribing event, translating to 30–100 minutes saved per week for active prescribers. Combined with reduced claim edits and fewer documentation-related denials, the operational impact extends beyond time savings into measurable revenue protection.

"A lot of our clinicians chose JotPsych over their EHR's built-in scribe because ours is actually built for behavioral health," Bierfeldt said. "Now they're using us for more than scribing. And we want to keep earning that by building the workflows they actually need."

"We started by being the best at documentation for behavioral health, and our users kept telling us what they needed next," Peereboom said. "E-prescribing is a big one."

JotRx is now available to all JotPsych users.

About JotPsych

JotPsych (SmartScribe Corp) is an AI-powered RCM and billing platform for behavioral health that integrates payer-aware clinical scribing with audit intelligence, certified e-prescribing, scheduling, patient communications, structured forms, lab order generation, and advanced document creation—ensuring documentation is compliant, claim-ready, and directly connected to the prescribing workflow. For more information, visit www.jotpsych.com.

For media or career inquiries, please reach out to [email protected].

SOURCE JotPsych

21%

more press release views with 
Request a Demo

Modal title

Also from this source

JotPsych Debuts JotAudit, Turning Behavioral-Health Documentation Into a Standardized, AI-Driven Audit System

JotPsych Debuts JotAudit, Turning Behavioral-Health Documentation Into a Standardized, AI-Driven Audit System

JotPsych, creator of the leading AI scribe for behavioral health, today announced the launch of JotAudit, an audit-intelligence platform that...

JotPsych Secures $5M Seed Round from Base10 Partners, Fast-Tracking Transition to First Fully Agentic EHR

JotPsych, creator of the leading AI scribe for behavioral health, today announced it has raised $5 million in seed funding led by Base10 Partners....

More Releases From This Source

Explore

Health Care & Hospitals

Health Care & Hospitals

Computer & Electronics

Computer & Electronics

Medical Pharmaceuticals

Medical Pharmaceuticals

Pharmaceuticals

Pharmaceuticals

News Releases in Similar Topics

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform Login
  • ProfNet
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform Login
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2026 Cision US Inc.